To examine LU’s ability to block progestin-induced secretion of VEGF from breast cancer cells, T47-D cells were treated for 18 h with MPA, both with and without LU or RU-486, then release of VEGF into the culture medium measured. This evidence concerns the gene VEGFA and breast carcinoma.